Martin Pharmaceuticals Announces Presentation of Positive Results from the DREAM Study and the Allowance of a Key Patent for its Innovative Ascites Treatment
NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Martin Pharmaceuticals, a clinical-stage pharmaceutical company targeting complications of advanced liver disease, today announced that results from its DREAM study will be presented